Cargando…
Scoliosis Orthopedic Surgery Combined With Nusinersen Intrathecal Injection Significantly Improved the Outcome of Spinal Muscular Atrophy Patient: A Case Report
BACKGROUND: Spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by pathogenic variation of the survival motor neuron (SMN) 1 gene. Symptoms of SMA include progressive limb muscle weakness, atrophy, and severe scoliosis. Nusinersen is an antisense oligonucleotide that can enhance...
Autores principales: | Xu, Beiyu, Wei, Cuijie, Hu, Xiao, Li, Wenzhu, Huang, Zhen, Que, Chengli, Qiu, Jianxing, Li, Chunde, Xiong, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082934/ https://www.ncbi.nlm.nih.gov/pubmed/35547367 http://dx.doi.org/10.3389/fneur.2022.869230 |
Ejemplares similares
-
Ultrasound-guided interlaminar approach for nusinersen administration in patients with spinal muscular atrophy with spinal fusion or severe scoliosis
por: Wei, Cuijie, et al.
Publicado: (2023) -
Intrathecal nusinersen administration in adult spinal muscular
atrophy patients with complex spinal anatomy
por: Cordts, Isabell, et al.
Publicado: (2020) -
Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience
por: Haché, Manon, et al.
Publicado: (2016) -
Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy
por: Kizina, Kathrin, et al.
Publicado: (2019) -
Ultra-low radiation dose protocol for CT-guided intrathecal nusinersen injections for patients with spinal muscular atrophy and severe scoliosis
por: Rosiak, Grzegorz, et al.
Publicado: (2021)